THESEUS PHARMACEUTICALS, INC. Deferred Tax Liabilities, Deferred Expense

THESEUS PHARMACEUTICALS, INC. Deferred Tax Liabilities, Deferred Expense

THESEUS PHARMACEUTICALS, INC. had Deferred Tax Liabilities, Deferred Expense of $114.00 thousand as of 2022-12-31, per its 10-K filed 2023-03-09.

Discontinued › Notes › Components of Deferred Tax Assets and Liabilities

us-gaap:DeferredTaxLiabilitiesDeferredExpense · last filed 2023-03-09

• 2022-12-31: Deferred Tax Liabilities, Deferred Expense $114.00K.
• 2021-12-31: Deferred Tax Liabilities, Deferred Expense $3.00K.